WallStreetZenWallStreetZen

NASDAQ: GLUE
Monte Rosa Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for GLUE

Based on 1 analyst offering 12 month price targets for Monte Rosa Therapeutics Inc.
Min Forecast
$11.00+72.14%
Avg Forecast
$11.00+72.14%
Max Forecast
$11.00+72.14%

Should I buy or sell GLUE stock?

Based on 1 analyst offering ratings for Monte Rosa Therapeutics Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GLUE stock forecasts and price targets.

GLUE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Credit Suisse
Bottom 25%
25
HoldReiterates$11.00+72.14%2023-08-11

1 of 1

Forecast return on equity

Is GLUE forecast to generate an efficient return?
Company
N/A
Industry
0.6%
Market
28.78%

Forecast return on assets

Is GLUE forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.1%

GLUE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GLUE$6.39$11.00+72.14%Hold
ERAS$2.12$9.33+340.24%Strong Buy
TERN$5.13$15.86+209.10%Buy
ABUS$1.94$6.00+209.28%Strong Buy
MGTX$5.18$25.67+395.50%Strong Buy

Monte Rosa Therapeutics Stock Forecast FAQ

Is Monte Rosa Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: GLUE) stock is to Hold GLUE stock.

Out of 1 analyst, 0 (0%) are recommending GLUE as a Strong Buy, 0 (0%) are recommending GLUE as a Buy, 1 (100%) are recommending GLUE as a Hold, 0 (0%) are recommending GLUE as a Sell, and 0 (0%) are recommending GLUE as a Strong Sell.

If you're new to stock investing, here's how to buy Monte Rosa Therapeutics stock.

What is GLUE's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: GLUE) forecast ROE is N/A, which is considered weak.

What is GLUE's Price Target?

According to 1 Wall Street analyst that have issued a 1 year GLUE price target, the average GLUE price target is $11.00, with the highest GLUE stock price forecast at $11.00 and the lowest GLUE stock price forecast at $11.00.

The Wall Street analyst predicted that Monte Rosa Therapeutics's share price could reach $11.00 by Aug 11, 2024. The average Monte Rosa Therapeutics stock price prediction forecasts a potential upside of 72.14% from the current GLUE share price of $6.39.

What is GLUE's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: GLUE) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.1%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.